#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#

Defining the Pathways Underlying the Prolonged PR Interval in Atrioventricular Conduction Disease


article has not abstract


Vyšlo v časopise: Defining the Pathways Underlying the Prolonged PR Interval in Atrioventricular Conduction Disease. PLoS Genet 8(12): e32767. doi:10.1371/journal.pgen.1003154
Kategorie: Perspective
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.pgen.1003154

Souhrn

article has not abstract


Zdroje

1. FeinbergWM, BlackshearJL, LaupacisA, KronmalR, HartRG (1995) Prevalence, age distribution, and gender of patients with atrial fibrillation. Analysis and implications. Arch Intern Med 155: 469–473.

2. GoAS, HylekEM, PhillipsKA, ChangY, HenaultLE, et al. (2001) Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA 285: 2370–2375.

3. KrahnAD, ManfredaJ, TateRB, MathewsonFA, CuddyTE (1995) The natural history of atrial fibrillation: incidence, risk factors, and prognosis in the Manitoba Follow-Up Study. Am J Med 98: 476–484.

4. WolfL (1943) Familial auricular fibrillation. N Engl J Med 229: 396–397.

5. FoxCS, PariseH, D'AgostinoRBSr, Lloyd-JonesDM, VasanRS, et al. (2004) Parental atrial fibrillation as a risk factor for atrial fibrillation in offspring. JAMA 291: 2851–2855.

6. SinnerMF, EllinorPT, MeitingerT, BenjaminEJ, KaabS (2011) Genome-wide association studies of atrial fibrillation: past, present, and future. Cardiovasc Res 89: 701–709.

7. DarbarD, HerronKJ, BallewJD, JahangirA, GershBJ, et al. (2003) Familial atrial fibrillation is a genetically heterogeneous disorder. J Am Coll Cardiol 41: 2185–2192.

8. LodderEM, SciclunaBP, MilanoA, SunAY, TangH (2012) Dissection of a quantitative trait locus for PR interval duration identifies Tnni3k as a novel modulator of cardiac conduction. PLoS Genet 8: e1003113 doi:10.1371/journal.pgen.1003113.

9. RemmeCA, SciclunaBP, VerkerkAO, AminAS, van BrunschotS, et al. (2009) Genetically determined differences in sodium current characteristics modulate conduction disease severity in mice with cardiac sodium channelopathy. Circ Res 104: 1283–1292.

10. SciclunaBP, WildeAA, BezzinaCR (2008) The primary arrhythmia syndromes: same mutation, different manifestations. Are we starting to understand why? J Cardiovasc Electrophysiol 19: 445–452.

11. LaiZF (2009) TNNI3K could be a novel molecular target for the treatment of cardiac diseases. Recent Pat Cardiovasc Drug Discov 4: 203–210.

12. WheelerFC, TangH, MarksOA, HadnottTN, ChuPL, et al. (2009) Tnni3k modifies disease progression in murine models of cardiomyopathy. PLoS Genet 5: e1000647 doi:10.1371/journal.pgen.1000647.

Štítky
Genetika Reprodukčná medicína

Článok vyšiel v časopise

PLOS Genetics


2012 Číslo 12
Najčítanejšie tento týždeň
Najčítanejšie v tomto čísle
Kurzy

Zvýšte si kvalifikáciu online z pohodlia domova

Aktuální možnosti diagnostiky a léčby litiáz
nový kurz
Autori: MUDr. Tomáš Ürge, PhD.

Všetky kurzy
Prihlásenie
Zabudnuté heslo

Zadajte e-mailovú adresu, s ktorou ste vytvárali účet. Budú Vám na ňu zasielané informácie k nastaveniu nového hesla.

Prihlásenie

Nemáte účet?  Registrujte sa

#ADS_BOTTOM_SCRIPTS#